↑↓ navigate open esc close
Czech Republic NEN contract award · ocds-ted-362048-2026-4

Czechia – Antineoplastic agents – Léčivé přípravky s obsahem inotuzumab ozogamicinu, trastuzumabu, nivolumabu, ipilimuma

Fakultní nemocnice Hradec Králové awarded Kč76.8M to Bristol-Myers Squibb spol. s r.o. for Professional Services & Consulting in May 2026 — one of 1,134 awards this buyer has made, above its typical award size.

27 May 2026
Award date
Kč76.8M
Contract value
1,134 Awards
Kč13.9M Avg award
Above vs typical
98 Awards
16 Buyers
Kč7.6B Total won

Contract description

Czechia – Antineoplastic agents – Léčivé přípravky s obsahem inotuzumab ozogamicinu, trastuzumabu, nivolumabu, ipilimumabu, amivantanabu, mosunetuzumabu

Premium

Related awards · Fakultní nemocnice Hradec Králové

1,134 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

1,090 more awards from this buyer · full history & CSV export

Premium

Other wins · Bristol-Myers Squibb spol. s r.o.

98 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Fakultní nemocnice Hradec Králové and Bristol-Myers Squibb spol. s r.o. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up